Back to
Los Angeles Capital Management LLC
TGTX
23 quarters
Position history for
Los Angeles Capital Management LLC's holdings in TG Therapeutics, Inc.
Yes. Los Angeles Capital Management holds 10,728 shares of TGTX (TG Therapeutics), worth $589,396, as of its Q2 2026 13F filing. It reduced the position by 13,643 shares (-56.0%) from Q1 2026. Los Angeles Capital Management has held TGTX since Q1 2022, across 18 quarterly 13F filings.
Current Value
$589,396
Current Shares
10,728
Total Value Change
+$363,396
Total Shares Change
-870
Quarter-by-Quarter History
Other major holders of TGTX: BlackRock, Inc., FMR LLC